We are conducting a study to determine if an FDA-approved medication can improve cognitive symptoms associated with systemic lupus erythematosus (“lupus brain fog”).
The study involves four visits that will occur over 12-14 weeks at one of our three study sites. You will receive either study drug or placebo. Blood will be drawn at each visit. All materials will be provided to you, and you will not be asked to change your current treatment. You may qualify for the study if you are:
Between 18-69 years old
English-speaking
Not pregnant
Not diagnosed with a severe psychiatric disease
- Nashville, Tennessee
- Vanderbilt University Medical Center
- Contact: Jon Williams
- Email: jon.williams@vumc.org
- Phone: 615-875-9200
- Cleveland, Ohio
- The Cleveland Clinic
- Contact: Saima Goul
- Email: gouls@ccf.org
- Phone: 216-444-4887
- Houston, Texas
- The University of Texas Health Science Center, Houston
- Contact: Touqeer Khan
- Email: Touqeer.Khan@uth.tmc.edu
- Phone: 713-500-6879
COMPENSATION WILL BE PROVIDED FOR YOUR TIME